Basal Cell Carcinoma Superficial

• FDA approval · 2024-09-16
  FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)

  FDA approved a supplemental application for ZYCLARA (imiquimod) filed by Bausch Health US, LLC.

• FDA approval · 2011-04-15
  FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves Sun Pharmaceutical Industries' imiquimod generic under an Original Application (ANDA 200173) for the same indications as the br…

• FDA approval · 2010-09-07
  FDA Approved: IMIQUIMOD — Original Application (Padagis Israel Pharmaceuticals Ltd)

  The FDA approved Padagis Israel Pharmaceuticals Ltd's imiquimod generic (ANDA 078837) for actinic keratosis, superficial basal cell carcinom…